CEP164 antibody (AA 730-829)

Catalog No. ABIN6138417

This anti-CEP164 antibody is a Rabbit Polyclonal antibody detecting CEP164 in WB and IHC. Suitable for Human.

Quick Overview for CEP164 antibody (AA 730-829) (ABIN6138417)

Target: CEP164 (Centrosomal Protein 164kDa (CEP164))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CEP164 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Product Details anti-CEP164 Antibody

Binding Specificity: AA 730-829

Sequence: EASEKSEQAA LNAAKEKALQ QLREQLEGER KEAVATLEKE HSAELERLCS SLEAKHREVV SSLQKKIQEA QQKEEAQLQK CLGQVEHRVH QKSYHVAGYE

Cross-Reactivity: Human, Mouse, Rat

Characteristics: Polyclonal Antibodies

Purification: Affinity purification

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 730-829 of human CEP164 (NP_055771.4).

Isotype: IgG

Application Details

Application Notes: WB,1:500 - 1:2000,IHC,1:50 - 1:200

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Avoid freeze / thaw cycles.

Target Details for CEP164

Target: CEP164 (Centrosomal Protein 164kDa (CEP164))

Alternative Name: CEP164

Background: This gene encodes a centrosomal protein involved in microtubule organization, DNA damage response, and chromosome segregation. The encoded protein is required for assembly of primary cilia and localizes to mature centrioles. Defects in this gene are a cause of nephronophthisis-related ciliopathies. Two transcript variants encoding different isoforms have been found for this gene.,CEP164,NPHP15,Epigenetics & Nuclear Signaling,DNA Damage & Repair,Cell Biology & Developmental Biology,Cell Cycle,Centrosome,CEP164

Molecular Weight: 163 kDa/164 kDa

Gene ID: 22897

UniProt: Q9UPV0

Pathways: M Phase